术后外科重症监护患者持续输注氯胺酮:系统评价与随机对照试验荟萃分析及GRADE分级
该系统评价与荟萃分析纳入9项随机对照试验共666例术后外科ICU患者,比较持续术后氯胺酮输注与非氯胺酮输注用于镇痛镇静。结果显示,氯胺酮显著减少成人24小时阿片类药物消耗(均数差-5.77 mg吗啡当量,95%CI -6.32至-5.23,p<0.0001),但48小时及儿科亚组差异无统计学意义;12、24、48小时疼痛评分组间相当。氯胺酮未显著缩短机械通气时间(均数差-0.84小时,95%CI -1.93至0.24)或ICU住院时间(均数差-0.97小时,95%CI -1.95至0.02),但术后恶心呕吐发生率更低(RR 0.59,95%CI 0.36-0.98,p=0.0399)。精神模拟不良事件少见且未显著增加。
要点
- 成人术后外科ICU患者持续低剂量氯胺酮输注可减少24小时阿片类药物消耗(均数差-5.77 mg吗啡当量,95%CI -6.32至-5.23,p<0.0001),证据确定性为中等。
- 氯胺酮输注未显著改善12、24、48小时疼痛评分,疼痛评分组间相当。
- 氯胺酮输注与术后恶心呕吐发生率降低相关(RR 0.59,95%CI 0.36-0.98,p=0.0399)。
- 氯胺酮未显著缩短机械通气时间(均数差-0.84小时,95%CI -1.93至0.24)或ICU住院时间(均数差-0.97小时,95%CI -1.95至0.02)。
- 精神模拟不良事件(如幻觉)少见且未显著增加;48小时阿片消耗减少及儿科亚组差异无统计学意义。
适用人群与场景
- 术后收入外科ICU的成人及儿科手术患者(纳入9项随机对照试验共666例)。
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入9项随机对照试验,共666例患者;检索PubMed、Cochrane Central和ClinicalTrials.gov自建库至2025年7月。
- 主要终点:成人24小时阿片类药物累积消耗(标准化为静脉吗啡当量)均数差-5.77 mg(95%CI -6.32至-5.23,p<0.0001);48小时消耗减少及儿科亚组差异无统计学意义。
- 疼痛评分:12、24、48小时疼痛评分组间相当。
- 次要终点:术后恶心呕吐发生率RR 0.59(95%CI 0.36-0.98,p=0.0399);机械通气时间均数差-0.84小时(95%CI -1.93至0.24);ICU住院时间均数差-0.97小时(95%CI -1.95至0.02),均未达统计学显著。
- 不良事件:精神模拟不良事件(如幻觉)少见且未显著增加。
- 证据确定性:成人24小时阿片消耗为中等,其余结局为低至极低。
证据类型、等级与局限
- 证据类型:随机对照试验的系统评价与荟萃分析,采用GRADE分级。
- 证据等级:成人24小时阿片消耗为中等确定性,其余结局为低至极低确定性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于术后外科ICU患者,持续低剂量氯胺酮输注可作为辅助镇痛策略以轻度减少24小时阿片类药物用量并降低术后恶心呕吐发生率,但不应期望其改善疼痛评分或缩短机械通气时间及ICU住院时间。
- 作者认为需要不同给药方案的大规模试验来探索氯胺酮在镇痛和减少术后恶心呕吐之外的最佳作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Optimal pain and sedation management in intensive care unit (ICU) remains challenging. While opioids and benzodiazepines are widely used, their adverse effects highlight the need for alternative or adjunctive strategies. Ketamine, with its analgesic and opioid-sparing has been proposed as an adjuvant. However, current evidence regarding its efficacy in ICU patients, particularly within the surgical population, remains inconclusive. We evaluated whether continuous low-dose ketamine infusion in postoperative surgical ICU patients reduces opioid consumption and improves pain intensity, and whether it affects opioid-related adverse events and key ICU recovery outcomes.
METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing continuous postoperative ketamine infusion versus non-ketamine based infusion for analgesia & sedation in patients admitted to the surgical ICU. Literature searches were performed in PubMed, Cochrane Central, and ClinicalTrials.gov from inception until July 2025. The primary endpoints were cumulative opioid consumption in the first 24-48 h (standardized to IV morphine equivalents where applicable) and rest pain intensity at prespecified early postoperative timepoints. Secondary endpoints included PONV, psychotomimetic events (e.g., hallucinations), and ICU recovery outcomes (e.g., ICU length of stay and duration of mechanical ventilation) when reported. We performed random-effects meta-analyses and assessed certainty using GRADE.
RESULTS: Nine RCTs comprising 666 patients were included. Ketamine significantly reduced opioid consumption at 24 h in adults (mean difference [MD] - 5.77 mg morphine equivalents; 95% CI - 6.32 to - 5.23; p < 0.0001), although the reduction at 48 h and in pediatric subgroups was not statistically significant. Pain scores at 12, 24, and 48 h were comparable between the groups. Ketamine did not significantly shorten the mechanical ventilation time (MD - 0.84 h; 95% CI - 1.93 to 0.24) or ICU length of stay (MD - 0.97 h; 95% CI - 1.95 to 0.02). However, ketamine use was associated with a lower incidence of PONV (RR 0.59; 95% CI 0.36-0.98; p = 0.0399). Psychotomimetic adverse events were infrequent and not significantly increased. GRADE evidence was moderate for opioids in adults at 24 h and low to very low for the remaining outcomes.
CONCLUSIONS: In postoperative surgical ICU patients, continuous low-dose ketamine infusion provides modest opioid sparing and is associated with lower PONV, without clear improvements in pain scores or ICU recovery outcomes. Large-scale trials with different dosing protocols are needed to explore the optimal role of ketamine beyond analgesia and PONV reduction.
参考来源
- Alzmmam AI, Alghanem RF, Alshahrani A, et al. Continuous ketamine infusion for surgical patients in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment. Crit Care. 2026. PMID: 41578281. doi:10.1186/s13054-026-05858-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。